Author Archives: Kristy

New Year Message From Committee Chair

Dear Members, I just wanted to update you on what we are up to and what is planned for 2013. We had a very successful annual meeting last year and your committee is about to embark upon planning this year’s … Continue reading

0 Comments

ISCTM Award

The International Society for CNS Clinical Trials and Methodology (ISCTM) is looking for new investigators as potential candidates for their new award program.  Interested parties can find further information by clicking below: https://isctm.org/NewInvestigator_2013

Comments Off on ISCTM Award

Phase I Accreditation Scheme Update – Deadline Extension

Following a successful meeting concerning improving the MHRA Phase 1 Accreditation Scheme on the 26th October, please click here for a summary of discussions and actions. We would appreciate your comments by the 20th January 2013 to info@ahppi.org.uk.    

Comments Off on Phase I Accreditation Scheme Update – Deadline Extension

Phase I Accreditation Scheme Update – Stakeholder Meeting 26th October 2012

The AHPPI has been invited by the MHRA to participate in a stakeholder group to discuss an update to the current Phase I Accreditation Scheme on Friday 26th October. The AHPPI will be represented by Peter Dewland and Graham Ridout. Please review the documentation and … Continue reading

Comments Off on Phase I Accreditation Scheme Update – Stakeholder Meeting 26th October 2012

Response to TOPS

Please see link to letter by Richmond Pharmacology in response to the earlier TOPS article by Boyce et al. Berelowitz et al A pan-European registration system for volunteer participation is within sight

0 Comments

MHRA GCP Consultative Committee Meeting

The GCP inspectorate organises a GCP consultative committee with relevant interested parties, and answering any queries. For example, relating to GCP issues, GCP inspections and also parliamentary questions. The GCP Inspectorate holds symposia every year, in which updates from the … Continue reading

Comments Off on MHRA GCP Consultative Committee Meeting